Your browser doesn't support javascript.
loading
Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Tandstad, Torgrim; Dahl, Olav; Cohn-Cedermark, Gabriella; Cavallin-Stahl, Eva; Stierner, Ulrika; Solberg, Arne; Langberg, Carl; Bremnes, Roy M; Laurell, Anna; Wijkstrøm, Hans; Klepp, Olbjørn.
Affiliation
  • Tandstad T; Department of Oncology, St Olavs University Hospital, Olav Kyrres gt 17, 7006 Trondheim, Norway. torgrim.tandstad@stolav.no
J Clin Oncol ; 27(13): 2122-8, 2009 May 01.
Article in En | MEDLINE | ID: mdl-19307506
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Germ Cell and Embryonal Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: J Clin Oncol Year: 2009 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Germ Cell and Embryonal Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: J Clin Oncol Year: 2009 Document type: Article Affiliation country: Country of publication: